Please login to the form below

Not currently logged in
Email:
Password:

US votes for low cost prescription drug imports

The US House of Representatives has passed a law that will allow the importation of lower-cost prescription drugs from regions outside the US, including Canada, Australia and Europe.

The US House of Representatives has passed a law that will allow the importation of lower-cost prescription drugs from regions outside the US, including Canada, Australia and Europe.

The legislation follows the passing of a USD 91bn spending measure, which funds farm subsidies and nutrition programmes for the budget year starting from October 2007.

The bill faces a veto from President Bush over its price tag, while the administration also opposes the drug importation provision. It says it would effectively permit individuals, wholesalers and pharmacists to import lower cost US-made and FDA-approved prescription drugs from Canada and other countries.

Under current law, US consumers are permitted to buy a 90-day supply in Canada.

Overseas drugs can cost two-thirds less than those in the US, where prices for brand-name drugs are among the highest globally. Outside the US, prices are lower because they are controlled by government regulation.

The White House says there is no system in place to protect consumers from counterfeit or unsafe drugs, but an administration policy statement stops short of an outright veto threat.

A move supported by drug companies to strike the drug importation provisions from the bill was defeated 283-146.

3rd August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics